Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
marianna.nalli@uniroma1.it
Marianna Nalli
Ricercatore
Struttura:
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
E-mail:
marianna.nalli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses
ACS INFECTIOUS DISEASES
2024
Development of N-(4-(1 H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability
JOURNAL OF MEDICINAL CHEMISTRY
2024
RS6077 induces mitotic arrest and selectively activates cell death in human cancer cell lines and in a lymphoma tumor in vivo
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2023
Hyaluronan-estradiol nanogels as potential drug carriers to target ER+ breast cancer cell line
CARBOHYDRATE POLYMERS
2023
Targeting the Grb2 cSH3 domain: design, synthesis and biological evaluation of the first series of modulators
BIOORGANIC CHEMISTRY
2023
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE
2023
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells
JOURNAL OF MEDICINAL CHEMISTRY
2023
Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2022
Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly Inhibitor
JOURNAL OF MEDICINAL CHEMISTRY
2022
Emerging Direct Targeting β-Catenin Agents
MOLECULES
2022
Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2021
CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme
EUROPEAN JOURNAL OF PHARMACOLOGY
2021
Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer
BIOLOGY DIRECT
2021
Discovery of a novel class of norovirus inhibitors with high barrier of resistance
PHARMACEUTICALS
2021
Emerging therapeutic agents for colorectal cancer
MOLECULES
2021
Discovery of new 1,1'-biphenyl-4-sulfonamides as selective subnanomolar human carbonic anhydrase II inhibitors
ACS MEDICINAL CHEMISTRY LETTERS
2020
Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2020
Discovery of Zika virus NS2B/NS3 inhibitors that prevent mice from fife-threatening infection and brain damage
ACS MEDICINAL CHEMISTRY LETTERS
2020
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2020
Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
2020
1
2
seguente ›
ultima »
Progetti di Ricerca
Brain-penetrant microtubule-targeting agents.
New 3-Aroyl-1-arylpyrroles (ARAPs) as anticancer drugs thought an interaction at Colchicine site of Tubulin
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma